CCL2 and acute kidney injury: In this regard, crotonate administration, which by increasing the substrate promoted histone crotonylation, increased kidney SIRT3 and PGC-1α expression in vivo and in cultured cells, while decreasing CCL2 expression and protecting from AKI [43].